In the last trading session, 1.68 million shares of the Galectin Therapeutics Inc (NASDAQ:GALT) were traded, and its beta was 0.71. Most recently the company’s
Galectin Therapeutics Inc (NASDAQ:GALT)’s traded shares stood at 0.44 million during the latest session, with the company’s beta value hitting 0.72. At the last check
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
